Skip to main content

Table 3 Clinical profile of diabetic patients and controls with and without PCO

From: Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus

Clinical Parameter Diabetic subjects Controls P value (ANOVA)
  PCO (n = 64) Non-PCO (n = 41) PCO (n = 22) Non-PCO (n = 38)  
Age (years), Mean ± SD 36.8 ± 4.28* 35.2 ± 4.4 34.2 ± 4.5 35.5 ± 4.6 0.000
Duration of DM (y), Mean ± SD 4.19 ± 2.0 2.9 ± 1.6 a -- -- 0.000
Age of menarche (y), Mean ± SD 13.5 ± 0.8 13.50 ± 0.6 13.1 ± 0.8 13.1 ± 0.7 0.015
Menstrual irregularity, 24 (37.5%) 4 (9.8%) 0 0 0.000
Oligomenorrhea 12 (18.8%) 1 (2.4%)    
Polymenorrhea 1 (1.6%) 1 (2.4%)    
Mennorrhagia 11 (17.2%) 2 (4.9%)    
Infertility 4 (6.2%) 0 0 0 0.368
Hirsuitism 9 (14.1%) 0 4 (18.2%) 2 (5.3%) 0.030
Acne 3 (4.7%) 0 1 (4.5%) 1 (2.6%) 0.564
Acanthosis 2 (3.1%) 0 0 0 0.368
History of hypertension 40 (78%) 30 (73%) 0 0 0.000
SBP (mmHg), Mean ± SD 140 ± 12.7 139 ± 12.3 138 ± 9.5 130 ± 9.3 b 0.000
DBP (mmHg), Mean ± SD 85.8 ± 7.8 83.3 ± 7.3 82.1 ± 10.2 80.58 ± 7.5 0.012
BMI (kg/m2), Mean ± SD 25.8 ± 3.1 24.7 ± 3.3 26.36 ± 2.8 25.34 ± 3.3 0.180
Waist to hip ratio, Mean ± SD 0.94 ± 0.6 0.92 ± 0.7 0.94 ± 0.6 0.92 ± 0.6 0.426
Ovarian volume (ml), Mean ± SD 5.80 ± 1.18 4.13 ± 1.07 5.98 ± 1.28 3.89 ± 0.88 0.000
PCOS 39 (61%) 0 15 (68%) 0 0.000
  1. * on ultrasonography
  2. a: P < 0.05, in the subject group, b: P < 0.05, in control group
  3. PCOS by Rotterdam ASRM/ESHRE consensus criteria